Carl Zeiss Meditec AG (MEX:AFXN) FFO


MEX:AFXN Carl Zeiss Meditec AG MEX:AFXN
68 GF Score
Price MXN3,258.20
GF Value MXN8,900.18
! 4 Warning Signs
View Full Analysis

What is Carl Zeiss Meditec AG FFO?

FFO (Funds from operations) only applies to REITs.

MEX:AFXN
68GF Score
Carl Zeiss Meditec AG MEX:AFXN
FFO is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Is Carl Zeiss Meditec AG (MEX:AFXN) Overvalued in 2026?

Based on GuruFocus' analysis, Carl Zeiss Meditec AG stock appears to be undervalued. The current stock price of MXN3,258.20 is trading 63.4% below its estimated GF Value™ of MXN8,900.18.

Key valuation signals for MEX:AFXN:

  • FFO:
  • GF Value™: MXN8,900.18 vs. price of MXN3,258.20 (63.4% below fair value)
  • GF Score™: 68/100 with 4 warning signs

No single metric tells the full story. See the MEX:AFXN stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Carl Zeiss Meditec AG Business Description

Address Goschwitzer Strasse 51-52, Jena, TH, DEU, 07745
Carl Zeiss Meditec is one of the largest visioncare technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up about 75% of sales in 2025, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
68GF Score

Get the complete analysis for MEX:AFXN

FFO is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

MXN3,258.20
Price
MXN8,900.18
GF Value